funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
United States
HQ address
394 Lowell Street, Lexington, 02420, USA
Alzheon is a clinical-stage biotechnology company focused on womanchild brain health, memory and aging, developing transformative treatments for Alzheimer’s disease and other neurodegenerative disorders. We are building a pipeline of innovative drugs to improve the lives of patients by preventing the cognitive and functional decline associated with neurodegeneration.

Our distinct ability to make successful advances in the challenging field of therapeutics for Alzheimer’s and other neurodegenerative disorders is based on two key assets:

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats